You are here:
Publication details
Sorafenib and sunitinib in metastatic renal cell carcinoma: Cost-effectiveness analysis in reimbursement proceedings vs. data from clinical practice
Authors | |
---|---|
Year of publication | 2010 |
Type | Conference abstract |
MU Faculty or unit | |
Citation |